Structural Basis for the Presentation of Tumor-Associated MHC Class II-Restricted Phosphopeptides to CD4+ T Cells
- 18 June 2010
- journal article
- Published by Elsevier in Journal of Molecular Biology
- Vol. 399 (4) , 596-603
- https://doi.org/10.1016/j.jmb.2010.04.037
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Structural alterations in peptide–MHC recognition by self-reactive T cell receptorsCurrent Opinion in Immunology, 2009
- Identification of tumor-associated, MHC class II-restricted phosphopeptides as targets for immunotherapyProceedings of the National Academy of Sciences, 2009
- Identification of Natural MHC Class II Presented Phosphopeptides and Tumor-Derived MHC Class I PhospholigandsJournal of Proteome Research, 2009
- Phosphorylated self-peptides alter human leukocyte antigen class I-restricted antigen presentation and generate tumor-specific epitopesProceedings of the National Academy of Sciences, 2009
- Phosphorylation-dependent interaction between antigenic peptides and MHC class I: a molecular basis for the presentation of transformed selfNature Immunology, 2008
- Tumors reveal their secrets to cytotoxic T cellsProceedings of the National Academy of Sciences, 2006
- Identification of class I MHC-associated phosphopeptides as targets for cancer immunotherapyProceedings of the National Academy of Sciences, 2006
- Minor Structural Changes in a Mutated Human Melanoma Antigen Correspond to Dramatically Enhanced Stimulation of a CD4+ Tumor-infiltrating Lymphocyte LineJournal of Molecular Biology, 2002
- XtalView/Xfit—A Versatile Program for Manipulating Atomic Coordinates and Electron DensityJournal of Structural Biology, 1999
- [20] Processing of X-ray diffraction data collected in oscillation modePublished by Elsevier ,1997